| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/25/2007 | US20070020277 Human Oncogene Induced Secreted Protein I |
| 01/25/2007 | US20070020276 Methods for the treatment of carcinoma |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020271 Endothelial cell specific antibodies and uses thereof |
| 01/25/2007 | US20070020262 Uses of mammalian cytokine: related reagents |
| 01/25/2007 | US20070020248 Process for biological tissue |
| 01/25/2007 | US20070020244 Fiber constructs and process of fiber fabrication |
| 01/25/2007 | US20070020239 HEXIMI as a suppressor of HIV replication and cardiac hypertrophy |
| 01/25/2007 | US20070020238 Method of targeted gene delivery using viral vectors |
| 01/25/2007 | US20070020237 Glucose inducible insulin expression and methods of treating diabetes |
| 01/25/2007 | US20070020236 Defective sindbis viral vectors |
| 01/25/2007 | US20070020235 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | US20070020234 Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
| 01/25/2007 | US20070020230 Use of chemokines, and pharmaceutical preparations containing the same |
| 01/25/2007 | US20070020224 Protein-proteophore complexes |
| 01/25/2007 | CA2657953A1 Alpha-synuclein antibodies and methods related thereto |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | CA2612949A1 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746157A1 Method of proliferating plasma cell |
| 01/24/2007 | EP1745799A2 Compositions and methods of treating tumors |
| 01/24/2007 | EP1745797A2 Vascularization inhibitors |
| 01/24/2007 | EP1745295A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 01/24/2007 | EP1745151A1 Compositions and methods for treating disorders associated with abnormal phosphate metabolism |
| 01/24/2007 | EP1744788A2 Combinatorial methods and compositions for treatment of melanoma |
| 01/24/2007 | EP1744780A2 Cancer treatment using viruses and camptothecins |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | EP1238092B1 Bovine immunodeficiency virus (biv) based vectors |
| 01/24/2007 | EP1180525B1 Transcriptional activation inhibitory protein |
| 01/24/2007 | EP1123414B1 Antisense modulation of integrin alpha 4 expression |
| 01/24/2007 | EP0951536B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | EP0935001B9 Novel vegf-like factors |
| 01/24/2007 | EP0843961B1 Chimeric animal and method for constructing the same |
| 01/24/2007 | EP0811073B1 Use of immune modulators for making medicaments ot inhibit immune responses against co-administered recombinant viruses |
| 01/24/2007 | EP0760000B1 Alphavirus expression vector |
| 01/24/2007 | CN1902314A Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 01/24/2007 | CN1902312A Method of constructing transgenic dendritic cell |
| 01/24/2007 | CN1901939A Treatment of proliferative diseases using an antisense IAP oligomer and chemotherapeutic agent |
| 01/24/2007 | CN1901907A Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 01/24/2007 | CN1901903A Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders |
| 01/24/2007 | CN1899622A Applying method for using magnetic field in magnetic particles |
| 01/23/2007 | US7166698 Mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166461 Animal growth regulator |
| 01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
| 01/23/2007 | US7166302 Complexing agents for compositions containing inclusion complexes |
| 01/23/2007 | US7166298 Genetic immunization with cationic lipids |
| 01/23/2007 | US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers |
| 01/23/2007 | US7166279 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 01/23/2007 | US7166277 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator |
| 01/23/2007 | CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof |
| 01/18/2007 | WO2007009094A2 Antisense antibacterial method and compound |
| 01/18/2007 | WO2007009064A2 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 01/18/2007 | WO2007008982A2 Methods and composition for modulating foxo1 activity and insulin signaling |
| 01/18/2007 | WO2007008821A2 Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (rbp), and/or serum retinol-rbp modulation |
| 01/18/2007 | WO2007008496A1 Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
| 01/18/2007 | WO2007008486A2 Aav vectors encoding superoxide dismutase |
| 01/18/2007 | WO2007008485A2 Prevention of chronic rejection in solid organ transplantation |
| 01/18/2007 | WO2007008220A2 Gene or drug delivery system |
| 01/18/2007 | WO2007007921A1 Segmented genome type recombinant mononegavirus vector |
| 01/18/2007 | WO2007007787A1 Non-human gene-disrupted animal having adam11 gene disruption |
| 01/18/2007 | WO2007006581A2 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/18/2007 | WO2007006101A1 Surface proteins of pasteurella multocida |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006123248A3 Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject |
| 01/18/2007 | WO2006116660A3 Methods of inhibiting a gpr23 |
| 01/18/2007 | WO2006105954A3 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types |
| 01/18/2007 | WO2006091965A3 Nod1 as an anti-tumor agent |
| 01/18/2007 | WO2006073760A3 Regulation of mink in thymocytes and t lymphocytes |
| 01/18/2007 | WO2006033756A3 Multiple rna polymerase iii promoter expression constructs |
| 01/18/2007 | WO2006026002A3 T cell receptors with enhanced sensitivity recognition of antigen |
| 01/18/2007 | WO2005117991A3 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| 01/18/2007 | WO2005113017A3 Gfap-based gene therapy for treatment of retinal diseases |
| 01/18/2007 | WO2005111058A9 Intracellular delivery of osteoinductive proteins and peptides |
| 01/18/2007 | WO2005084307A3 Use of lipid conjugates in the treatment of disease |
| 01/18/2007 | WO2004084837A3 Methods and compositions for treating and preventing inflammatory conditions |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | US20070016968 Treatment of pain through expression of opioid receptors |
| 01/18/2007 | US20070016967 Novel IFNgamma-like polypeptides |
| 01/18/2007 | US20070015913 Mrp3 genes and uses thereof |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015724 performing an immunoassay to detect an increase in the level of a polypeptide, relative to that in a non-cancer biological sample from the same tissue; gene expression inhibition of disease-related proteins; medical prognosis |
| 01/18/2007 | US20070015723 Antiviral oligonucleotides having a conserved G4 core sequence |
| 01/18/2007 | US20070015722 A first oligonucletide and a second are complimentary and hybridize with each other to a target nucleic acid for their use in modulating gene expression; hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA |
| 01/18/2007 | US20070015721 Hiv-gag codon-optimised dna vaccines |
| 01/18/2007 | US20070015282 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070015253 Heterologous; biologically active protein fused via a proteolytic cleavage site to a latency associated peptide which having a precursor domain of transforming growth factor beta; overcomes the toxic effect of systemic administration of potent biological agents |
| 01/18/2007 | US20070015242 Expression vector comprising nucleotide sequences coding C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of vision defcets associated with cell proliferative disorders |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015217 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease |
| 01/18/2007 | US20070015202 Atlastin |
| 01/18/2007 | US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 01/18/2007 | US20070015161 Drug screening for mitotic inhibitor drugs; cancer |
| 01/18/2007 | US20070015150 Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland |
| 01/18/2007 | US20070015149 Prlz regulatory elements in the treatment of disease and the discovery of therapeutics |
| 01/18/2007 | US20070015148 Gene expression profiles in breast tissue |
| 01/18/2007 | US20070015144 Human cDNAs and proteins and uses thereof |